Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
about
Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetesGPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesityNew insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-cateninProteins and small molecules for cellular regenerative medicineThe role of physical exercise in inflammatory bowel diseaseRole of microRNAs in islet beta-cell compensation and failure during diabetesFunctional characterization of N-terminally GFP-tagged GLP-1 receptorInhibition of dipeptidyl peptidase IV (DPP IV) is one of the mechanisms explaining the hypoglycemic effect of berberineThe Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune DiseaseIdentification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assaysIdentification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (Part II): in silico prediction in antidiabetic extractsEnhanced beta-cell mass without increased proliferation following chronic mild glucose infusionLinagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesityIleal interposition surgery improves glucose and lipid metabolism and delays diabetes onset in the UCD-T2DM rat.Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway.Identification of small-molecule inducers of pancreatic beta-cell expansionCMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studiesRole and development of GLP-1 receptor agonists in the management of diabetes.Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist.JNK3 is required for the cytoprotective effect of exendin 4The evolving place of incretin-based therapies in type 2 diabetesAlteration of peripheral blood lymphocyte subsets in acute pancreatitis.Incretin effect of Urena lobata leaves extract on structure and function of rats islet β-cells.Sitagliptin (MK0431) inhibition of dipeptidyl peptidase IV decreases nonobese diabetic mouse CD4+ T-cell migration through incretin-dependent and -independent pathways.Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapiesDifferences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.Can we protect the gut in critical illness? The role of growth factors and other novel approaches.Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery.Pancreas-specific Gsalpha deficiency has divergent effects on pancreatic alpha- and beta-cell proliferationDose combinations of exendin-4 and salmon calcitonin produce additive and synergistic reductions in food intake in nonhuman primatesGIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene.Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes.GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasisIncretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryDipeptidyl peptidase IV (DPP IV) inhibitors: A newly emerging drug class for the treatment of type 2 diabetes.Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus.Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-fat diet-induced obesity.Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trialTranscriptome analysis of food habit transition from carnivory to herbivory in a typical vertebrate herbivore, grass carp Ctenopharyngodon idella.Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass
P2860
Q24564844-6DF14166-39F4-4C40-B55D-F59F3B646DBFQ24653673-46EEB555-AE2B-4C97-BCD7-CA6DD1A13D46Q26823824-408F73CC-42CD-4854-9DA5-0F18D046DA9DQ26850495-43E9EB70-A29C-45C9-B214-686319C32D44Q26865777-1B20BDB0-E75E-48EC-B05F-11EC6B37F28AQ26995308-8AB7FCD8-782A-45C0-9B03-FCD123077900Q27865242-1F88CB99-DBFA-4507-A63B-F2647D75EF39Q28253310-0CE29622-CEE6-4EB8-A349-3A1CDACEB34DQ28276657-3C1269DC-20E5-47F0-8E37-5D96AB050A4FQ28483681-20975E33-EC41-45DD-960D-F7D885ED7CCFQ28483936-B4F6A6E3-FECA-4B56-9158-51944D7A58CEQ28581365-C57EAD8F-DBD2-4205-9F5A-4E69AA743E5CQ28728101-3F23E907-B018-4530-801D-8E2C28EE6111Q30494837-4B75AE04-F6DB-47C7-AC0B-C72D03790331Q33400744-2FD56E06-1E5A-4F1C-BD82-8BFEB8C48CC7Q33402400-1ACF2E4B-0787-48E9-85BE-BC2E553B3A23Q33559925-703079A3-1966-460C-ADA6-AE65EB53F299Q33635830-96F79201-B153-47A5-9827-CEB85A397E56Q33697296-AC4716A7-D8FD-4719-8AE8-22664ADF2015Q33852246-F2ABE147-B9C0-4431-9069-EB5644D2EE1DQ33866808-E649B961-C545-48E6-8550-E496E9E84CF9Q33869398-11C334EF-57F0-4F63-8E81-B7705C1EF800Q33896508-2E1CEA35-EBC2-4AA0-BD20-EA167ADC059AQ33930280-59AAA96E-DA65-4A6F-B1E9-CCD78FD404F8Q33949425-8362052A-2796-417C-AE00-4304C7E21089Q33959406-211F51A5-BEFC-4BFB-8F62-84F96B8F3B88Q34014020-8B90070F-8F9F-4045-B5E4-006E8FAB068FQ34022466-BEF647C0-A98E-4B77-9F10-F0E4E300E082Q34090004-6A1662BF-CC9B-43B8-A1D2-6F48D2505C4DQ34150227-1CD16C2D-C1C1-41B6-A077-52D138C84A14Q34187972-91BFF51A-1EAE-45DC-8459-A7AC5753A6D9Q34273302-50960BA5-D94D-46F8-B98B-E10D86EFD62CQ34339666-C4FE954C-8D88-48D8-BF57-A90540440DCCQ34362412-A8E0DF66-BFD0-4573-89C1-A7B63669719EQ34589793-584BEF6C-968D-4945-A6FA-090FFB1905CBQ34620447-9E7A40A4-7164-4326-A73B-311DD6FA440EQ34622388-13B8E706-369C-46EC-B119-08789F8E1A2BQ34745045-80028A0F-F1A1-46B8-B714-BA329888A503Q35015933-281A5901-D446-47BB-B6DF-DA57D3A6D502Q35055522-BA66D743-8B36-429E-A759-BE032348CC80
P2860
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Minireview: Glucagon-like pept ...... t, and central nervous system.
@ast
Minireview: Glucagon-like pept ...... t, and central nervous system.
@en
type
label
Minireview: Glucagon-like pept ...... t, and central nervous system.
@ast
Minireview: Glucagon-like pept ...... t, and central nervous system.
@en
prefLabel
Minireview: Glucagon-like pept ...... t, and central nervous system.
@ast
Minireview: Glucagon-like pept ...... t, and central nervous system.
@en
P356
P1433
P1476
Minireview: Glucagon-like pept ...... t, and central nervous system.
@en
P2093
Brubaker PL
Drucker DJ
P304
P356
10.1210/EN.2004-0015
P407
P577
2004-03-24T00:00:00Z